Novel substituted sulfamide derivatives

Details for Australian Patent Application No. 2009274266 (hide)

Owner Janssen Pharmaceutica NV

Inventors McComsey, David F.; Parker, Michael H.

Agent Shelston IP

Pub. Number AU-A-2009274266

PCT Pub. Number WO2010/011548

Priority 61/082,654 22.07.08 US

Filing date 15 July 2009

Wipo publication date 28 January 2010

International Classifications

C07D 319/20 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/011548 Priority application(s): WO2010/011548

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009274270-Flotation reagents and flotation processes utilizing same

2009274258-Fuel efficiency improvement for locomotive consists